hopTo Inc.

2023 Q4 Form 10-Q Financial Statement

#000149315223042162 Filed on November 20, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.610M
YoY Change 9.24%
Cash & Equivalents $5.605M
Short-Term Investments $0.00
Other Short-Term Assets $120.0K
YoY Change -61.18%
Inventory
Prepaid Expenses
Receivables $466.8K
Other Receivables $0.00
Total Short-Term Assets $6.194M
YoY Change 6.62%
LONG-TERM ASSETS
Property, Plant & Equipment $2.900K
YoY Change -52.46%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $22.90K
YoY Change 0.0%
Total Long-Term Assets $54.50K
YoY Change -38.21%
TOTAL ASSETS
Total Short-Term Assets $6.194M
Total Long-Term Assets $54.50K
Total Assets $6.248M
YoY Change 5.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $241.2K
YoY Change -2.03%
Accrued Expenses $70.50K
YoY Change -12.96%
Deferred Revenue $1.337M
YoY Change 18.67%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.913M
YoY Change 19.48%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $160.0K
YoY Change -54.79%
Total Long-Term Liabilities $160.0K
YoY Change -54.79%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.913M
Total Long-Term Liabilities $160.0K
Total Liabilities $2.077M
YoY Change 6.22%
SHAREHOLDERS EQUITY
Retained Earnings -$77.98M
YoY Change -0.29%
Common Stock $1.900K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.171M
YoY Change
Total Liabilities & Shareholders Equity $6.248M
YoY Change 5.95%

Cashflow Statement

Concept 2023 Q4 2023 Q3

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Central Index Key
EntityCentralIndexKey
0001021435
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q2 HPTO Stock Issued During Period Value Issuance Of Shares Due To Exercise Of Warrants
StockIssuedDuringPeriodValueIssuanceOfSharesDueToExerciseOfWarrants
usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
usd
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Entity File Number
EntityFileNumber
0-21683
dei Entity Registrant Name
EntityRegistrantName
hopTo Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-3899021
dei Entity Address Address Line1
EntityAddressAddressLine1
189 North Main St.
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 102
dei Entity Address City Or Town
EntityAddressCityOrTown
Concord
dei Entity Address State Or Province
EntityAddressStateOrProvince
NH
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
03301
dei City Area Code
CityAreaCode
(800)
dei Local Phone Number
LocalPhoneNumber
472-7466
dei Security12b Title
Security12bTitle
Common
dei Trading Symbol
TradingSymbol
HPTO
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
18976165 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5605400 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5037300 usd
CY2022Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
318700 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
466800 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
511200 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
121500 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
102600 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
6193700 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
5969800 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
28700 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
51600 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2900 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5300 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
22900 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
22900 usd
CY2023Q3 us-gaap Assets
Assets
6248200 usd
CY2022Q4 us-gaap Assets
Assets
6049600 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
241200 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
234200 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
70500 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
61800 usd
CY2023Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
236600 usd
CY2022Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
150000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
28400 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
10300 usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1336500 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1206100 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1913200 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1662400 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
40900 usd
CY2023Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
163600 usd
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
264800 usd
CY2023Q3 us-gaap Liabilities
Liabilities
2076800 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1968100 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
195000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
195000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18976165 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18976165 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18826342 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18826342 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
1900 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1900 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
82145100 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
82145100 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-77975600 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-78065500 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
4171400 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
4081500 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6248200 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6049600 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1069600 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
980200 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3171100 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2892000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
67300 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
49800 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
221900 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
176000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
1002300 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
930400 usd
us-gaap Gross Profit
GrossProfit
2949200 usd
us-gaap Gross Profit
GrossProfit
2716000 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
211000 usd
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
248600 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
879400 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
687600 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
218100 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
429900 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
845600 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
800700 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
450400 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
379000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1263300 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1142500 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
879500 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
1057500 usd
us-gaap Operating Expenses
OperatingExpenses
2988300 usd
us-gaap Operating Expenses
OperatingExpenses
2630800 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
122800 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-127100 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-39100 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
85200 usd
CY2022Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-17800 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
17700 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-103300 usd
CY2023Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
67100 usd
CY2022Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
500 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
111300 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
1500 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
67100 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-17300 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
129000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-101800 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
189900 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-144400 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
89900 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16600 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
189900 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-144400 usd
us-gaap Net Income Loss
NetIncomeLoss
89900 usd
us-gaap Net Income Loss
NetIncomeLoss
-16600 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18976165 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18846664 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18899957 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18848658 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18976165 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18846664 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18899957 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18848658 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3968600 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
106500 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
4075100 usd
CY2022Q2 HPTO Stock Issued During Period Value Purchase Of Common Stock
StockIssuedDuringPeriodValuePurchaseOfCommonStock
-10100 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
21300 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
4086300 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-144400 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
3941900 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
4081500 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
34600 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
4116100 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-134600 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
3981500 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
3981500 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
189900 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
189900 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
4171400 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
4171400 usd
us-gaap Net Income Loss
NetIncomeLoss
89900 usd
us-gaap Net Income Loss
NetIncomeLoss
-16600 usd
us-gaap Depreciation
Depreciation
2400 usd
us-gaap Depreciation
Depreciation
2100 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-1700 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2000 usd
us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
17600 usd
us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
-103400 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-46100 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-192400 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
18900 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
261500 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
102300 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
31000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-400 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
29200 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
23800 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
231700 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
76200 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
10100 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
336400 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
336400 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10100 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
568100 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
66100 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5037300 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4755300 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5605400 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4821400 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_849_eus-gaap--UseOfEstimates_zHSIpy20jq69" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_znIONTbXVqLh">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reported periods. Amounts could materially change in the future. These estimates include the valuation of the allowances for doubtful accounts, depreciation of long-lived assets, timing of revenue recognized over time, allowances for deferred tax assets and accruals of liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Noncurrent
AllowanceForDoubtfulAccountsReceivableNoncurrent
3900 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Noncurrent
AllowanceForDoubtfulAccountsReceivableNoncurrent
5600 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84D_eus-gaap--ConcentrationRiskCreditRisk_zeYt0CnDN9yj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86B_z6QLv2lsVZ5f">Concentration of Credit Risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the nine months ended September 30, 2023 and 2022, the Company had three resellers comprising <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--ResellersOneMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zSkQrS46odV4" title="Concentration of credit risk percentage">16.4</span>%,<span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--ResellersTwoMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zGKrz7ZAihGd" title="Concentration of credit risk percentage">15.3</span>%, and <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--ResellersThreeMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zqfPi6yLwdw3" title="Concentration of credit risk percentage">12.9</span>%, and three resellers comprising <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--ResellersOneMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zHF51GdEl7ll" title="Concentration of credit risk percentage">13.4</span>%, <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--ResellersTwoMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z5ta3d1BXk9l" title="Concentration of credit risk percentage">12.3%</span> and <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--ResellersThreeMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zlkq7DdnKuE2" title="Concentration of credit risk percentage">12.3%</span>, respectively, of total sales.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2023 and December 31, 2022, the Company had four resellers comprising <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230101__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--ResellersOneMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zpuljylaOeN" title="Concentration of credit risk percentage">28.0</span>%, <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230101__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--ResellersTwoMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zF53XPIAW9C6" title="Concentration of credit risk percentage">22.8</span>%,<span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230101__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--ResellersThreeMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zbTDfgGNmCm9" title="Concentration of credit risk percentage">19.4</span>% and <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230101__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--ResellersFourMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z1mm6jS9EQ2j" title="Concentration of credit risk percentage">12.4</span>%, and four resellers comprising <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--ResellersOneMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zSffB5DuKmzk" title="Concentration of credit risk percentage">18.5</span>%, <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--ResellersTwoMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z9wFbuuA0Nad" title="Concentration of credit risk percentage">18.3</span>%, <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--ResellersThreeMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zXTRuYj5oij2" title="Concentration of credit risk percentage">17.4</span>% and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--ResellersFourMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z0z0Skz1XvQ3" title="Concentration of credit risk percentage">16.0</span>%, respectively, of net accounts receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the purposes of this description, “sales” refers to the dollar value of orders received from these customers and partners in the period indicated. The sales values do not necessarily equal recognized revenue for these periods due to our revenue recognition policies which require deferral of revenue associated with prepaid software service fees. The loss of one of these resellers would not have a material impact as the Company could take over the end customer relationship.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
HPTO Number Of Common Shares Equivalents Of Outstanding In Money Warrants
NumberOfCommonSharesEquivalentsOfOutstandingInMoneyWarrants
0 shares
HPTO Number Of Common Shares Equivalents Of Outstanding In Money Warrants
NumberOfCommonSharesEquivalentsOfOutstandingInMoneyWarrants
248216 shares
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3200 shares
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
164000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
165700 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
161100 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
160400 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2900 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5300 usd
us-gaap Depreciation
Depreciation
2400 usd
us-gaap Depreciation
Depreciation
2100 usd
CY2023Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
0 shares
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
149216 shares
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1069600 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
980200 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3171100 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2892000 usd
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
11400 usd
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
16000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
7900 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
20700 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
28600 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
200 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
28400 usd
us-gaap Lease Expiration Date1
LeaseExpirationDate1
2024-08-31

Files In Submission

Name View Source Status
hpto-20230930_cal.xml Edgar Link unprocessable
0001493152-23-042162-index-headers.html Edgar Link pending
0001493152-23-042162-index.html Edgar Link pending
0001493152-23-042162.txt Edgar Link pending
0001493152-23-042162-xbrl.zip Edgar Link pending
ex-31.htm Edgar Link pending
ex-32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
form10-q_001.jpg Edgar Link pending
hpto-20230930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
hpto-20230930_def.xml Edgar Link unprocessable
hpto-20230930_lab.xml Edgar Link unprocessable
hpto-20230930_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
Show.js Edgar Link pending